Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors-Reference-Cited by-全球学者库

Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

Published:2018-08-06 Issue:10 Volume:7 Page:1-9
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lin Zhiyuan¹,Liu Li¹,Xia Yu¹,Chen Xiang¹,Xiong Ying¹,Qu Yang¹,Wang Jiajun¹,Bai Qi¹,Guo Jianming¹,Xu Jiejie²^ORCID

Affiliation:

1. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai China

2. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai China

Funder

National Natural Science Foundation of China

Zhongshan Hospital Talented Youth Program

Zhongshan Hospital Science Foundation

Shanghai Health and Family Planning Commission

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1477461

Reference46 articles.

1. Global cancer statistics, 2012

2. Cancer statistics, 2017

3. Renal-Cell Carcinoma

4. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

5. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer;Scientific Reports;2024-01-04

2. Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature;Scientific Reports;2023-10-16

3. Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy;Redox Biology;2023-09

4. B cells in tumor metastasis: friend or foe?;International Journal of Biological Sciences;2023

5. Pan‐cancer analysis revealing DAAM1 as a novel predictive biomarker for PD‐1/PD‐L1 blockade in clear cell renal cell carcinoma;MedComm;2022-10-27